298 related articles for article (PubMed ID: 15565277)
1. Consensus proposals for the prevention of acute and delayed vomiting and nausea following high-emetic-risk chemotherapy.
Kris MG; Hesketh PJ; Herrstedt J; Rittenberg C; Einhorn LH; Grunberg S; Koeller J; Olver I; Borjeson S; Ballatori E
Support Care Cancer; 2005 Feb; 13(2):85-96. PubMed ID: 15565277
[TBL] [Abstract][Full Text] [Related]
2. Consensus recommendations for the prevention of vomiting and nausea following high-emetic-risk chemotherapy.
Kris MG; Tonato M; Bria E; Ballatori E; Espersen B; Herrstedt J; Rittenberg C; Einhorn LH; Grunberg S; Saito M; Morrow G; Hesketh P
Support Care Cancer; 2011 Mar; 19 Suppl 1():S25-32. PubMed ID: 20803039
[TBL] [Abstract][Full Text] [Related]
3. Consensus proposal for 5HT3 antagonists in the prevention of acute emesis related to highly emetogenic chemotherapy. Dose, schedule, and route of administration.
Gandara DR; Roila F; Warr D; Edelman MJ; Perez EA; Gralla RJ
Support Care Cancer; 1998 May; 6(3):237-43. PubMed ID: 9629876
[TBL] [Abstract][Full Text] [Related]
4. Antiemetic therapy for multiple-day chemotherapy and high-dose chemotherapy with stem cell transplant: review and consensus statement.
Einhorn LH; Rapoport B; Koeller J; Grunberg SM; Feyer P; Rittenberg C; Aapro M
Support Care Cancer; 2005 Feb; 13(2):112-6. PubMed ID: 15480812
[TBL] [Abstract][Full Text] [Related]
5. Antiemetic Prophylaxis for Chemotherapy-Induced Nausea and Vomiting.
Navari RM; Aapro M
N Engl J Med; 2016 Apr; 374(14):1356-67. PubMed ID: 27050207
[No Abstract] [Full Text] [Related]
6. Delayed emesis: moderately emetogenic chemotherapy.
Roila F; Warr D; Clark-Snow RA; Tonato M; Gralla RJ; Einhorn LH; Herrstedt J
Support Care Cancer; 2005 Feb; 13(2):104-8. PubMed ID: 15549426
[TBL] [Abstract][Full Text] [Related]
7. Antiemetic therapy for multiple-day chemotherapy and additional topics consisting of rescue antiemetics and high-dose chemotherapy with stem cell transplant: review and consensus statement.
Einhorn LH; Grunberg SM; Rapoport B; Rittenberg C; Feyer P
Support Care Cancer; 2011 Mar; 19 Suppl 1():S1-4. PubMed ID: 20505956
[TBL] [Abstract][Full Text] [Related]
8. Impact of 5-HT(3) RA selection within triple antiemetic regimens on uncontrolled highly emetogenic chemotherapy-induced nausea/vomiting.
Schwartzberg L; Jackson J; Jain G; Balu S; Buchner D
Expert Rev Pharmacoecon Outcomes Res; 2011 Aug; 11(4):481-8. PubMed ID: 21711119
[TBL] [Abstract][Full Text] [Related]
9. Aprepitant plus palonosetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving multiple-day cisplatin chemotherapy.
Gao HF; Liang Y; Zhou NN; Zhang DS; Wu HY
Intern Med J; 2013 Jan; 43(1):73-6. PubMed ID: 22141732
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of triplet regimen antiemetic therapy for chemotherapy-induced nausea and vomiting (CINV) in bone and soft tissue sarcoma patients receiving highly emetogenic chemotherapy, and an efficacy comparison of single-shot palonosetron and consecutive-day granisetron for CINV in a randomized, single-blinded crossover study.
Kimura H; Yamamoto N; Shirai T; Nishida H; Hayashi K; Tanzawa Y; Takeuchi A; Igarashi K; Inatani H; Shimozaki S; Kato T; Aoki Y; Higuchi T; Tsuchiya H
Cancer Med; 2015 Mar; 4(3):333-41. PubMed ID: 25533447
[TBL] [Abstract][Full Text] [Related]
11. 2016 Updated MASCC/ESMO Consensus Recommendations: Prevention of Nausea and Vomiting Following High Emetic Risk Chemotherapy.
Herrstedt J; Roila F; Warr D; Celio L; Navari RM; Hesketh PJ; Chan A; Aapro MS
Support Care Cancer; 2017 Jan; 25(1):277-288. PubMed ID: 27443154
[TBL] [Abstract][Full Text] [Related]
12. State of the Art Antiemetic Therapy for Cancer Patients.
Lau TK; Yip CH; Yeo W
Curr Oncol Rep; 2016 Jan; 18(1):2. PubMed ID: 26694923
[TBL] [Abstract][Full Text] [Related]
13. Reviewing current and emerging antiemetics for chemotherapy-induced nausea and vomiting prophylaxis.
Natale JJ
Hosp Pract (1995); 2015; 43(4):226-34. PubMed ID: 26308912
[TBL] [Abstract][Full Text] [Related]
14. Randomized, double-blind, placebo-controlled, phase III cross-over study evaluating the oral neurokinin-1 antagonist aprepitant in combination with a 5HT3 receptor antagonist and dexamethasone in patients with germ cell tumors receiving 5-day cisplatin combination chemotherapy regimens: a hoosier oncology group study.
Albany C; Brames MJ; Fausel C; Johnson CS; Picus J; Einhorn LH
J Clin Oncol; 2012 Nov; 30(32):3998-4003. PubMed ID: 22915652
[TBL] [Abstract][Full Text] [Related]
15. [Medical treatment of chemotherapy-induced nausea and vomiting].
Herrstedt J
Ugeskr Laeger; 2007 Feb; 169(9):799-805. PubMed ID: 17355844
[TBL] [Abstract][Full Text] [Related]
16. Acute emesis: moderately emetogenic chemotherapy.
Herrstedt J; Koeller JM; Roila F; Hesketh PJ; Warr D; Rittenberg C; Dicato M
Support Care Cancer; 2005 Feb; 13(2):97-103. PubMed ID: 15565276
[TBL] [Abstract][Full Text] [Related]
17. Delayed emesis: moderately emetogenic chemotherapy (single-day chemotherapy regimens only).
Roila F; Warr D; Aapro M; Clark-Snow RA; Einhorn L; Gralla RJ; Herrstedt J; Saito M; Tonato M
Support Care Cancer; 2011 Mar; 19 Suppl 1():S57-62. PubMed ID: 21132332
[TBL] [Abstract][Full Text] [Related]
18. Guidelines for the control of nausea and vomiting with chemotherapy of low or minimal emetic potential.
Olver I; Clark-Snow RA; Ballatori E; Espersen BT; Bria E; Jordan K
Support Care Cancer; 2011 Mar; 19 Suppl 1():S33-6. PubMed ID: 20803222
[TBL] [Abstract][Full Text] [Related]
19. 2016 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following multiple-day chemotherapy, high-dose chemotherapy, and breakthrough nausea and vomiting.
Einhorn LH; Rapoport B; Navari RM; Herrstedt J; Brames MJ
Support Care Cancer; 2017 Jan; 25(1):303-308. PubMed ID: 27815710
[TBL] [Abstract][Full Text] [Related]
20. Antiemetics in children receiving chemotherapy.
Roila F; Feyer P; Maranzano E; Olver I; Clark-Snow R; Warr D; Molassiotis A
Support Care Cancer; 2005 Feb; 13(2):129-31. PubMed ID: 15538642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]